114 related articles for article (PubMed ID: 8747521)
21. Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues.
Brown MA; Stenberg LM; Persson U; Stenflo J
J Biol Chem; 2000 Jun; 275(26):19795-802. PubMed ID: 10779512
[TBL] [Abstract][Full Text] [Related]
22. gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin.
Naraki T; Kohno N; Saito H; Fujimoto Y; Ohhira M; Morita T; Kohgo Y
Biochim Biophys Acta; 2002 Apr; 1586(3):287-98. PubMed ID: 11997080
[TBL] [Abstract][Full Text] [Related]
23. Localization of the specific binding site for magnesium(II) ions in factor IX.
Sekiya F; Yoshida M; Yamashita T; Morita T
FEBS Lett; 1996 Sep; 392(3):205-8. PubMed ID: 8774845
[TBL] [Abstract][Full Text] [Related]
24. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
[TBL] [Abstract][Full Text] [Related]
25. Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX.
Freedman SJ; Blostein MD; Baleja JD; Jacobs M; Furie BC; Furie B
J Biol Chem; 1996 Jul; 271(27):16227-36. PubMed ID: 8663165
[TBL] [Abstract][Full Text] [Related]
26. Protein engineering of the hydrophobic domain of human factor IX.
Hughes PE; Handford PA; Austen DE; Brownlee GG
Protein Eng; 1994 Sep; 7(9):1121-7. PubMed ID: 7831283
[TBL] [Abstract][Full Text] [Related]
27. The entire gamma-carboxyglutamic acid- and helical stack-domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor.
Prorok M; Geng JP; Warder SE; Castellino FJ
Int J Pept Protein Res; 1996 Sep; 48(3):281-5. PubMed ID: 8897096
[TBL] [Abstract][Full Text] [Related]
28. Protein engineering of the propeptide of human factor IX.
Handford PA; Winship PR; Brownlee GG
Protein Eng; 1991 Feb; 4(3):319-23. PubMed ID: 1857716
[TBL] [Abstract][Full Text] [Related]
29. The propeptides of human protein C, factor VII, and factor IX are exchangeable with regard to directing gamma-carboxylation of these proteins.
Geng JP; Castellino FJ
Thromb Haemost; 1996 Aug; 76(2):205-7. PubMed ID: 8865532
[TBL] [Abstract][Full Text] [Related]
30. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
Bray GL; Weinmann AF; Thompson AR
J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
[TBL] [Abstract][Full Text] [Related]
31. Modification of the N-terminus of human factor IX by defective propeptide cleavage or acetylation results in a destabilized calcium-induced conformation: effects on phospholipid binding and activation by factor XIa.
Wojcik EG; Van Den Berg M; Poort SR; Bertina RM
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):629-36. PubMed ID: 9169594
[TBL] [Abstract][Full Text] [Related]
32. Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX.
Huang LH; Cheng H; Pardi A; Tam JP; Sweeney WV
Biochemistry; 1991 Jul; 30(30):7402-9. PubMed ID: 1854745
[TBL] [Abstract][Full Text] [Related]
33. The metal-dependent conformational changes in factor IX associated with phospholipid binding. Studies using antibodies against a synthetic peptide and chemical modification of factor IX.
Liebman HA
Eur J Biochem; 1993 Mar; 212(2):339-45. PubMed ID: 7680311
[TBL] [Abstract][Full Text] [Related]
34. Crystallization of an anti-factor IX antibody and its complex.
Shi X; Li Y; Bian C; Zhao G; Huang M
Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):701-3. PubMed ID: 15930624
[TBL] [Abstract][Full Text] [Related]
35. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations.
Sugo T; Mizuguchi J; Kamikubo Y; Matsuda M
Thromb Res; 1990 Jun; 58(6):603-14. PubMed ID: 2385830
[TBL] [Abstract][Full Text] [Related]
36. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
Astermark J; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
[TBL] [Abstract][Full Text] [Related]
37. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
Atoda H; Yoshida N; Ishikawa M; Morita T
Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of a human monoclonal antibody that interacts with a sulfated tyrosine-containing epitope of the GPIb receptor and inhibits platelet functions.
Hagay Y; Lahav J; Levanon A; Varon D; Brill A; Panet A
Mol Immunol; 2006 Feb; 43(5):443-53. PubMed ID: 16337487
[TBL] [Abstract][Full Text] [Related]
39. High-affinity calcium-binding site in the gama-carboxyglutamic acid domain of bovine factor VII.
Inoue K; Shimada H; Ueba J; Enomoto S; Tanaka-Saisaka Y; Kubota T; Koyama M; Morita T
Biochemistry; 1996 Oct; 35(43):13826-32. PubMed ID: 8901525
[TBL] [Abstract][Full Text] [Related]
40. Epitope mapping of human factor IX inhibitor antibodies.
Takahashi I; Mizumo S; Kamiya T; Takamatsu J; Saito H
Br J Haematol; 1994 Sep; 88(1):166-73. PubMed ID: 7528527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
